1 Followers USX:HTGM - HTG Molecular Diagnostics Inc (USD 0.3) HTG Molecular Diagnostics Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance

USD 0.3    -0.007 (-2.18%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


Overview

9 Apr 2020

Day Change: -0.007 (-2.18%)

52 Wk Range: 0.2671 - 2.826

Day's Range: 0.3 - 0.3285

Last Volume: 676,519

Current Yield: 0%

Projected Yield: 0%

Open: USD 0.31

9 Apr 2020

Metric HTGM S.Median
Beta 0.65 0.84
VaR 59.74 25.23
E.Shortfall 71.37 45.03
Liquidity 473.75K 95.2K

Fundamental

9 Apr 2020

PE: -0.556

Market Cap: 9.5M

Price Over Book: 0.337

Price Over Sales: 0.43

Return On Assets: -33.5%

Return On Equity: -60.6%

Price Over NAV: [Friends Only]

General

CEO: Timothy B. Johnson

Headquarters: Tucson

Employees: 107

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

HTG Molecular Diagnostics, Inc. develops and markets technology platforms that facilitate the routine use of complex molecular profiling. The company's HTG Edge and HTG EdgeSeq platforms consist of instrumentation, consumables, and software analytics that are used in molecular profiling applications, including tumor profiling, biomarker development and prospectively, and molecular diagnostic testing. The company's platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors or sales agents in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.